Prostate Cancer - Results from #500

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer. September 29, 2022

Freely Available, Fully Automated AI-Based Analysis of Primary Tumour and Metastases of Prostate Cancer in Whole-Body [18F]-PSMA-1007 PET-CT. September 29, 2022

Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy. September 29, 2022

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer. September 29, 2022

A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques. September 29, 2022

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer September 28, 2022

Standard and hypofractionated dose escalation to intraprostatic tumour nodules in localised prostate cancer: 5 year efficacy and toxicity in the DELINEATE trial. September 28, 2022

An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs. September 28, 2022

Predicting Local Failure after Partial Prostate Re-Irradiation Using a Dosiomic-Based Machine Learning Model. September 28, 2022

Value of magnetic resonance imaging/ultrasound fusion prostate biopsy to select patients for focal therapy. September 28, 2022

PSA-Stratified Performance of [18F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer Patients under Androgen Deprivation Therapy. September 28, 2022

Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database. September 27, 2022

Automatic segmentation of prostate and extracapsular structures in MRI to predict needle deflection in percutaneous prostate intervention. September 27, 2022

Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage. September 27, 2022

MRI vs Transrectal Ultrasound to Estimate Prostate Volume and PSAD: Impact on Prostate Cancer Detection. September 27, 2022

Addition of androgen receptor targeted agents to androgen deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. September 27, 2022

The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates. September 26, 2022

Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China. September 26, 2022

The Rapid Assessment for Prostate Imaging and Diagnosis (RAPID) prostate cancer diagnostic pathway. September 26, 2022

Allopurinol and prostate cancer survival in a Finnish population-based cohort. September 26, 2022

Page 26 of 1275

email news signup